Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IMMUNE CHECKPOINT INHIBITOR”

763 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 763 results

Large-scale testing (Phase 3)Looking for participantsNCT06989112
What this trial is testing

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Who this might be right for
Endometrial Cancer
AstraZeneca 600
Testing effectiveness (Phase 2)Looking for participantsNCT03645928
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Who this might be right for
Metastatic MelanomaSquamous Cell Carcinoma of the Head and NeckNon-small Cell Lung Cancer
Iovance Biotherapeutics, Inc. 245
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07376499
What this trial is testing

Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction

Who this might be right for
Small Cell Lung Cancer
China Medical University, China 31
Not applicableUnknownNCT05554432
What this trial is testing

Development of an EORTC Immune Checkpoint Inhibitor-specific Quality of Life Item List: Phase 1 & 2

Who this might be right for
CancerIMMUNE CHECKPOINT INHIBITORQuality of Life
Institut Curie 43
Post-approval studies (Phase 4)Not Yet RecruitingNCT07004335
What this trial is testing

Efficacy and Safety of Iparomlimab and Tuvonralimab Injection in Combination With Bevacizumab After Progression on Anti-PD-(L)1 Therapy in Advanced Melanoma: A Prospective, Single-Arm, Exploratory Clinical Study

Who this might be right for
PD-(L)1CTLA-4Advanced Melanoma+3 more
Hebei Medical University Fourth Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT06576921
What this trial is testing

Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction

Who this might be right for
Stomach NeoplasmsImmune Checkpoint Inhibitors
Xijing Hospital 116
Not applicableLooking for participantsNCT07191171
What this trial is testing

Impact of Dysbiosis-inducing Drugs on Effectivity of Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer Patients

Who this might be right for
Dysbiosis
University Hospital, Strasbourg, France 800
Not applicableActive Not RecruitingNCT06632106
What this trial is testing

HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC

Who this might be right for
Hepatic Arterial Infusion ChemotherapyTyrosine Kinase InhibitorImmune Checkpoint Inhibitors+1 more
First Hospital of China Medical University 97
Not applicableStudy completedNCT04204434
What this trial is testing

Biomarkers For Immune Checkpoint Inhibitors

Who this might be right for
Advanced CancerNeoplasms
Rhode Island Hospital 119
Early research (Phase 1)Ended earlyNCT03237572
What this trial is testing

Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Patrick Dillon, MD 13
Testing effectiveness (Phase 2)UnknownNCT06132698
What this trial is testing

Immune Checkpoint Inhibitors Intrathecal Injection in Patients With Leptomeningeal Metastases in NSCLC

Who this might be right for
NSCLC Associated With Leptomeningeal Metastases
West China Hospital 17
Not applicableNot Yet RecruitingNCT07527819
What this trial is testing

Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Peter MacCallum Cancer Centre, Australia 75
Not applicableStudy completedNCT05221398
What this trial is testing

Adjuvant Immune Checkpoint Inhibitors in Postoperative Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 517
Not applicableActive Not RecruitingNCT03695952
What this trial is testing

A Prospective Cohort Study of Patients with Hepatobiliary Cancer Treated with Immune Checkpoint Inhibitors

Who this might be right for
Hepatocellular CarcinomaBiliary Tract Cancer
Asan Medical Center 100
Not applicableStudy completedNCT04352335
What this trial is testing

Change in NLR and Survival Among Advanced Lung Cancer Patients Receiving ICIs With Immunomodulator

Who this might be right for
Advanced Lung Cancer
Chung Shan Medical University 53
Not applicableStudy completedNCT05332821
What this trial is testing

TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 1,244
Not applicableUnknownNCT04721184
What this trial is testing

Impact of Low Muscle Mass in HNC Treated With Immunotherapy

Who this might be right for
Head and Neck Small Cell CarcinomaSarcopenia
Institut Català d'Oncologia 120
Not applicableLooking for participantsNCT06566209
What this trial is testing

FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis

Who this might be right for
Subclinical Immune Checkpoint Inhibitor-Induced MyocarditisMyocarditisICI-Myocarditis+4 more
Mayo Clinic 30
Not applicableUnknownNCT03354936
What this trial is testing

ANRS CO24 OncoVIHAC (Onco VIH Anti Checkpoint)

Who this might be right for
HIV Infected Patients With Cancer Treated by ICPi
ANRS, Emerging Infectious Diseases 50
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Load More Results